Literature DB >> 31023729

Neuromyelitis optica spectrum disorder and adenocarcinoma of ovary: a novel association.

Julie Sachdeva1, Ramandeep Bansal2, Aastha Takkar1, Rajveer Singh1.   

Abstract

Paraneoplastic neuromyelitis optica spectrum disorder (NMOSD) is a rare clinical entity with less than 40 cases described in literature until today. Paraneoplastic NMOSD in association with adenocarcinoma of ovary has not been described yet. We present a case of paraneoplastic NMOSD in association with carcinoma ovary which improved following appropriate immunomodulation with pulse intravenous methylprednisolone and azathioprine. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  immunology; spinal cord; visual pathway

Mesh：

Substances：

Year:  2019        PMID： 31023729      PMCID： PMC6506012          DOI： 10.1136/bcr-2018-227435

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  17 in total

1.  Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

Authors:  Joanna Kitley; Maria Isabel Leite; Wilhelm Küker; Gerardine Quaghebeur; Jithin George; Patrick Waters; Mark Woodhall; Angela Vincent; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

2.  Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder?

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Int J Neurosci       Date:  2013-10-31       Impact factor: 2.292

3.  Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.

Authors:  Raffaele Iorio; Guido Rindi; Carmen Erra; Valentina Damato; Michela Ferilli; Mario Sabatelli
Journal:  Mult Scler       Date:  2015-02-25       Impact factor: 6.312

4.  Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.

Authors:  Khaled Moussawi; David J Lin; Marcelo Matiello; Sheena Chew; Daniel Morganstern; Henrikas Vaitkevicius
Journal:  J Clin Neurosci       Date:  2015-09-26       Impact factor: 1.961

Review 5.  Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

Authors:  Scott S Zamvil; Anthony J Slavin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-01-22

6.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

Review 7.  Aquaporin-4 autoimmunity.

Authors:  Anastasia Zekeridou; Vanda A Lennon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-05-21

8.  Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.

Authors:  Hee Kyung Yang; Se Joon Woo; Woong-Yang Park; Jeong-Min Hwang
Journal:  BMC Ophthalmol       Date:  2014-09-03       Impact factor: 2.209

9.  Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.

Authors:  Kerstin Soelberg; Stine R Larsen; Marlene T Moerch; Mads Thomassen; Klaus Brusgaard; Friedemannn Paul; Terry J Smith; Christian Godballe; Jakob Grauslund; Soeren T Lillevang; Nasrin Asgari
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-16

10.  Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.

Authors:  Yukio Takeshita; Birgit Obermeier; Anne C Cotleur; Simona F Spampinato; Fumitaka Shimizu; Erin Yamamoto; Yasuteru Sano; Thomas J Kryzer; Vanda A Lennon; Takashi Kanda; Richard M Ransohoff
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.